< Back to previous page
Researcher
Chantal Mathieu
- Disciplines:Endocrinology and metabolic diseases
Affiliations
- Clinical and Experimental Endocrinology (Division)
Member
From1 Oct 1999 → Today
Projects
71 - 75 of 75
- Synthesis and evaluation of new lead vitamin D analogs for autoimmune disorders.From17 Aug 2009 → 16 Aug 2011Funding: IOF - Industrial Research Fund
- Beckman Coulter Gallios flowcytometer.From20 Oct 2008 → 19 Apr 2015Funding: Hercules - Small and Medium size research infrastructure
- DF Expert Center Beta Cell Immunoprotection: an integrated approach form basic research to clinical intervention in type 1 diabetes.From1 Sep 2008 → 31 Oct 2013Funding: Foreign foundations, funds with scientific view
- ActoBiotics for antigen-specific intervention in type 1 diabetes: mono- and combination therapy.From1 Sep 2008 → 17 Jul 2014Funding: Baekeland
- Protecting the beta cell in type 1 diabetes mellitus through better understanding of the intracellular signaling cascades: interventions in pre-clinical models.From1 Jan 2008 → 31 Dec 2011Funding: FWO research project (including WEAVE projects)
Publications
1 - 10 of 713
- Effectiveness of a blended mobile-based lifestyle intervention in women with glucose intolerance after a recent history of gestational diabetes (MELINDA): a 1-year, prospective, multicentre, randomised controlled trial.(2024)
Authors: Chantal Mathieu, Christophe Matthys, Annick Bogaerts, Katrien Fouzia Benhalima
Pages: 102523 - Continuous Glucose Monitoring-Based Metrics and Hypoglycemia Duration in Insulin-Experienced Individuals With Long-standing Type 2 Diabetes Switched From a Daily Basal Insulin to Once-Weekly Insulin Icodec: Post Hoc Analysis of ONWARDS 2 and ONWARDS 4.(2024)
Authors: Chantal Mathieu
Pages: 729 - 738 - The Health Economics of Automated Insulin Delivery Systems and the Potential Use of Time in Range in Diabetes Modeling: A Narrative Review(2024)
Authors: Chantal Mathieu, Pieter Gillard
Pages: 66 - 75 - CD4+ T cells from individuals with type 1 diabetes respond to a novel class of deamidated peptides formed in pancreatic islets.(2024)
Authors: Rita Derua, Chantal Mathieu, Lut Overbergh
Pages: db230588 - The double burden: Navigating type 1 diabetes and obesity(2024)
Authors: Nele Steenackers, Chantal Mathieu, Bart Van Der Schueren
- Type 1 diabetes mellitus: a brave new world(2024)
Authors: Chantal Mathieu
Pages: 71 - 72 - Clinical care advice for monitoring of islet autoantibody positive individuals with presymptomatic type 1 diabetes(2024)
Authors: Kristina Casteels, Chantal Mathieu
- An Insulin-Chromogranin A Hybrid Peptide activates DR11 restricted T cells in human type 1 diabetes.(2024)
Authors: Chantal Mathieu, Lut Overbergh
Pages: db230622 - A first-in-human, open-label Phase 1b and a randomised, double-blind Phase 2a clinical trial in recent-onset type 1 diabetes with AG019 as monotherapy and in combination with teplizumab(2024)
Authors: Chantal Mathieu
- Hypoglycaemia after Initiation of CFTR Modulator Therapy in a Cystic Fibrosis Patient without Diabetes(2023)
Authors: Lieven Dupont, Natalie Lorent, Pieter Gillard, Bart Van Der Schueren, Ann Mertens, Chantal Mathieu, Roman Vangoitsenhoven
Patents
1 - 6 of 6
- Biomarkers for diabetes therapy (Inventor)
- Biomarkers for diabetes therapy (Inventor)
- Improved methods for pancreatic islet transplantation (Inventor)
- Citrullinated peptides for diagnosis or treatment of diabetes (Inventor)
- Improved methods for pancreatic islet transplantation (Inventor)
- RESISTANCE TO OXIDATIVE STRESS (Inventor)